NATCAPSUQ Natural Capsules Q2 FY26 results (Jul–Sep 2025) and concall
Natural Capsules Limited reported a challenging Q2 FY26 with revenue growth of 1.33% QoQ to ₹45.80 crores, but operating performance was impacted by external factors, leading to a negative EBITDA margin of 1.93% and a net loss of ₹6.99 crores. The company revised its full-year FY26 topline guidance downwards to ₹225 crores due to US tariffs affecting capsule demand and technical hurdles delaying API commercial production. Management is actively working to resolve these issues and remains confident in its long-term strategy.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 8.7%, net profit up 205.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 41 | 43 | 44 | 44 | 45 +9% |
| EBITDA | 5 | 5 | 5 | 5 | 5 +10% |
| Net profit | 1 | 2 | 3 | 3 | 3 +205% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
